Market revenue in 2023 | USD 593.1 million |
Market revenue in 2030 | USD 933.1 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Photodynamic Therapy Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.2% in 2023. Horizon Databook has segmented the Argentina drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare spending in Argentina accounts for ~7% of the total GDP. In this country, 70% to 75% of medical products are imported. The U.S. exports medical devices to Argentina as the country has the most technologically advanced products. Argentina remains a key market in Latin America for the U.S.
The U.S. is one of Argentina's noteworthy exporters and is among the three best FDI source countries. Imports of medical products must be performed by an importer registered with Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT), the Argentine equivalent to the U.S. FDA, as a frequent importer of medical devices.
According to The International Trade Administration, the market for medical devices and equipment in Argentina is dominated by imports, which make up between 65% and 80% of the total market. With a 17% import rate, the U.S. has historically been a major supplier of medical items to Argentina.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into Argentina drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account